View in EDS HTML Full Text PDF Full Text

SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.

Saved in:
Bibliographic Details
Title: SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.
Authors: Seidu, Samuel1 (AUTHOR), Alabraba, Vicki2 (AUTHOR), Davies, Sarah3 (AUTHOR), Newland-Jones, Philip4 (AUTHOR), Fernando, Kevin5 (AUTHOR), Bain, Stephen C.6,7 (AUTHOR), Diggle, Jane8 (AUTHOR), Evans, Marc9 (AUTHOR), James, June2 (AUTHOR), Kanumilli, Naresh10,11 (AUTHOR), Milne, Nicola10 (AUTHOR), Viljoen, Adie12 (AUTHOR), Wheeler, David C.13 (AUTHOR), Wilding, John P. H.14 (AUTHOR) j.p.h.wilding@liverpool.ac.uk
Source: Diabetes Therapy. May2024, Vol. 15 Issue 5, p1099-1124. 26p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18696953
DOI:10.1007/s13300-024-01550-5